← FDA Drug Approvals (Drugs@FDA)
ETHACRYNIC ACID
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2019-08-27
Drug application
- FDA Application #
ANDA211232- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ETHACRYNIC ACID
- Generic name
- ETHACRYNIC ACID
- Active ingredients
- ETHACRYNIC ACID
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- ScieGen Pharmaceuticals Inc
- First approval
- 2019-08-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown